메뉴 건너뛰기




Volumn 94, Issue 2, 2004, Pages 600-604

Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: Case report and literature review

Author keywords

Chemotherapy; Conservative management; Ovarian cancer; Pregnancy

Indexed keywords

CARBOPLATIN; PACLITAXEL;

EID: 3543123515     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.05.030     Document Type: Article
Times cited : (54)

References (10)
  • 1
    • 0025058457 scopus 로고
    • Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma
    • Malfetano J.H., Goldkrand J.W. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet. Gynecol. 75:1990;545-547
    • (1990) Obstet. Gynecol. , vol.75 , pp. 545-547
    • Malfetano, J.H.1    Goldkrand, J.W.2
  • 2
    • 0242384199 scopus 로고    scopus 로고
    • Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer
    • Mendez L.E., Mueller A., Salom E., Gonzales-Quintero V.H. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet. Gynecol. 5:2003;1200-1202
    • (2003) Obstet. Gynecol. , vol.5 , pp. 1200-1202
    • Mendez, L.E.1    Mueller, A.2    Salom, E.3    Gonzales-Quintero, V.H.4
  • 3
    • 0025855036 scopus 로고
    • Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy
    • King L.A., Nevin P.C., Williams P.P., Carson L. Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy. Gynecol. Oncol. 41:1991;78-80
    • (1991) Gynecol. Oncol. , vol.41 , pp. 78-80
    • King, L.A.1    Nevin, P.C.2    Williams, P.P.3    Carson, L.4
  • 5
    • 0033028202 scopus 로고    scopus 로고
    • Cis-platinum combination chemotherapy during pregnancy for mucinous cystadenocarcinoma of the ovary. Case report
    • Bayhan G., Aban M., Yayla M., Yaldiz M., Erden A.C. Cis-platinum combination chemotherapy during pregnancy for mucinous cystadenocarcinoma of the ovary. Case report. Eur. J. Gynaecol. Oncol. 20:1999;231-232
    • (1999) Eur. J. Gynaecol. Oncol. , vol.20 , pp. 231-232
    • Bayhan, G.1    Aban, M.2    Yayla, M.3    Yaldiz, M.4    Erden, A.C.5
  • 6
    • 0035209886 scopus 로고    scopus 로고
    • Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy
    • Sood A.K., Shahin M.S., Soroski J.I. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol. Oncol. 83:2001;599-600
    • (2001) Gynecol. Oncol. , vol.83 , pp. 599-600
    • Sood, A.K.1    Shahin, M.S.2    Soroski, J.I.3
  • 8
    • 0033868973 scopus 로고    scopus 로고
    • Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamid (CAP) regimen. Case report
    • Ohara N., Teramoto K. Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamid (CAP) regimen. Case report. Clin. Exp. Obstet. Gynecol. 27:2000;123-124
    • (2000) Clin. Exp. Obstet. Gynecol. , vol.27 , pp. 123-124
    • Ohara, N.1    Teramoto, K.2
  • 9
    • 2142759614 scopus 로고    scopus 로고
    • Use of chemotherapy during human pregnancy
    • Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 5:2004;283-291
    • (2004) Lancet Oncol. , vol.5 , pp. 283-291
    • Cardonick, E.1    Iacobucci, A.2
  • 10
    • 0037125582 scopus 로고    scopus 로고
    • Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON 3 randomised trial
    • International Collaborative Ovarian Neoplasm Group Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON 3 randomised trial. Lancet. 360:2002;505-515
    • (2002) Lancet , vol.360 , pp. 505-515


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.